Amedisys, Inc. (AMED)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
313.54+10.64 (+3.51%)
At close: 4:00PM EST
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 302.90 |
| Open | 304.98 |
| Bid | 285.80 x 800 |
| Ask | 314.10 x 900 |
| Day's Range | 301.91 - 314.41 |
| 52 Week Range | 132.95 - 314.41 |
| Volume | 212,619 |
| Avg. Volume | 165,429 |
| Market Cap | 10.287B |
| Beta (5Y Monthly) | 0.77 |
| PE Ratio (TTM) | 62.81 |
| EPS (TTM) | 4.99 |
| Earnings Date | Feb 16, 2021 - Feb 22, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 309.43 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-3% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
View moreRelated Research
- Simply Wall St.
Amedisys, Inc. (NASDAQ:AMED) Shares Could Be 34% Above Their Intrinsic Value Estimate
Does the January share price for Amedisys, Inc. ( NASDAQ:AMED ) reflect what it's really worth? Today, we will estimate...
- Zacks
Phirbo (PAHC) Nutritional Specialty Aids Growth, Low ASP Ails
Phirbo's (PAHC) net vaccine sales remain robust on higher international demand for poultry vaccines.
- Zacks
Abbott (ABT) to Expand in Booming TBI Space on New Approval
If positive, Abbott's (ABT) TBI blood test result complements CT scans to help evaluate whether a suspected patient has a TBI.
© 2021 Verizon Media. All rights reserved.
